[Study of c-erbB-2 expression in breast neoplasms]

Area of Science:

• Oncology
• Molecular Biology
• Pathology

Background:

• The c-erbB-2 protein, a key oncogene, plays a role in cell proliferation and differentiation.
• Aberrant expression of c-erbB-2 is implicated in the development and progression of various cancers, including breast cancer.

Purpose of the Study:

• To evaluate the expression of the c-erbB-2 protein in different types of breast neoplasms using immunohistochemistry.
• To determine the correlation between c-erbB-2 overexpression and clinicopathological features such as lymph node metastasis and mitotic activity in infiltrating ductal carcinoma.

Main Methods:

• Retrospective analysis of formalin-fixed paraffin-embedded breast neoplasm biopsies.
• Immunohistochemical staining using the monoclonal antibody NCL-CB11 against the c-erbB-2 protein.
• Correlation analysis of c-erbB-2 expression with tumor type, lymph node status, and mitotic figures.

Main Results:

• Positive membrane staining for c-erbB-2 was observed in 65/115 infiltrating ductal carcinomas, 11/15 intraductal carcinomas, and 17/22 mammary Paget's diseases.
• In infiltrating ductal carcinoma, c-erbB-2 overexpression positively correlated with axillary lymph node metastasis and a higher number of mitotic figures.
• These findings indicate gene amplification in the studied tumors.

Conclusions:

• c-erbB-2 overexpression is frequent in various breast neoplasms, particularly infiltrating ductal carcinoma.
• c-erbB-2 expression may serve as a predictive marker for poorer prognosis in breast carcinoma.
• The study discusses the broader implications of c-erbB-2 expression in other malignant and benign lesions.